clopidogrel has been researched along with ym-254890 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayashi, K; Kawasaki, T; Moritani, Y; Nagai, K; Saito, T; Shigenaga, T; Takamatsu, H; Takasaki, J; Taniguchi, M; Uemura, T | 1 |
| Kawasaki, T; Miyata, K; Takamatsu, H; Taniguchi, M; Tomura, Y; Uchida, W; Uemura, T; Yamamoto, E | 1 |
2 other study(ies) available for clopidogrel and ym-254890
| Article | Year |
|---|---|
Pharmacological properties of YM-254890, a specific G(alpha)q/11 inhibitor, on thrombosis and neointima formation in mice.
Topics: Administration, Oral; Animals; Blood Pressure; Carotid Arteries; Cell Proliferation; Chlorides; Chromones; Clopidogrel; Dose-Response Relationship, Drug; Enzyme Inhibitors; Ferric Compounds; GTP-Binding Protein alpha Subunits, Gq-G11; Heart Rate; Male; Mice; Mice, Inbred ICR; Models, Chemical; Morpholines; Muscle, Smooth; Muscle, Smooth, Vascular; Peptides, Cyclic; Platelet Aggregation; Thrombosis; Ticlopidine; Time Factors; Tunica Intima | 2005 |
Effect of YM-254890, a specific Galphaq/11 inhibitor, on experimental peripheral arterial disease in rats.
Topics: Animals; Aorta; Blood Flow Velocity; Blood Pressure; Clopidogrel; Dermis; Dose-Response Relationship, Drug; Endothelium, Vascular; Epoprostenol; GTP-Binding Protein alpha Subunits, Gq-G11; Heart Rate; Hindlimb; In Vitro Techniques; Lauric Acids; Male; Peptides, Cyclic; Peripheral Vascular Diseases; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Ticlopidine; Vasodilation; Vasodilator Agents | 2006 |